Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients

Documenti analoghi

• Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
  di: Kyndi, M, et al.
  Pubblicazione: (2005)
• Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
  di: Langerød, A, et al.
  Pubblicazione: (2000)
• Germline TP53 mutations in Finnish breast cancer patients
  di: Rapakko, K, et al.
  Pubblicazione: (2000)
• Clinical implications of germline mutations in breast cancer: TP53
  di: Schon, Katherine, et al.
  Pubblicazione: (2017)
• HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
  di: Andersen, TI, et al.
  Pubblicazione: (2000)